MILFORD, Mass. — Laboratory sciences company Waters Corp. has recognized the University of Maryland School of Pharmacy's Department of Pharmaceutical Sciences' mass spectrometry facility as the first to receive its Waters Centers of Innovation honors, the company announced at a ceremony Tuesday.
As part of the Centers of Innovation program, the school will receive priority access to new technologies, opportunities to influence the development of next-generation research instruments, shared opportunities for collaboration with Waters and priority applications support and funding assistance. Waters honored the school for its interdisciplinary research using mass spectrometry to discover new and improved drugs to treat cancer, diabetes and infections diseases.
"Today's ceremony is a testament to the achievements of this school," University of Maryland, Baltimore president Jay Perman said. "Our new mass spectrometry facility is the largest, most well-equipped and well-staffed facility of its kind in the Mid-Atlantic region, and it will enable us to shorten the time it takes to translate research findings into new diagnostics, therapeutics and preventive procedures that will help patients."